Bandim Health Project

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Bandim Health Project
Projecto de Saúde Bandim
Bandim Health Project.JPG
FounderProf. Peter Aaby
TypeNon-Governmental Organization
The INDEPTH Network
Prof. Peter Aaby[1]
National Research Coordinator
Amabelia Rodrigues
Parent organization
Statens Serum Institut[2]
AffiliationsUniversity of Southern Denmark
Center for Vitamins and Vaccines
WebsiteBandim Health Project

The Bandim Health Project works with population based health research in one of the world's poorest countries, Guinea-Bissau in West Africa.

The core of the project is a health and demographic surveillance system which registers more than 100,000 people in six suburbs of the capital Bissau. Furthermore, 182 representative clusters of 100 women and their children are followed in the rural areas. Information on health, diseases, immunisations, breast-feeding, etc. is collected, primarily focusing on women and children. Admissions to the country's sole pediatric ward in the capital are recorded.

The Bandim Health Project is member of the INDEPTH Network of health and demographic surveillance sites in Africa, Asia and Oceania.

Coordinates: 11°50′43.64″N 15°35′45.42″W / 11.8454556°N 15.5959500°W / 11.8454556; -15.5959500


The Bandim Health Project was initiated in 1978 by Peter Aaby. The project is currently based on collaboration between the Ministry of Health in Guinea-Bissau, Statens Serum Institut in Denmark, and researchers affiliated to The University of Southern Denmark, as well as the University of Aarhus, Denmark.

In 2012, the Danish National Research Foundation funded the establishment of the Center of Excellence, The Research Center for Vitamins and Vaccines (CVIVA) based on the Bandim Health Project and its research into non-specific effects of vaccines.

Fields of research[edit]

The Bandim Health Project works with population based health research, focusing on women and children. The project's fields of research include:

Important results[edit]

One of the most important findings was that a new measles vaccine used in low-income countries was associated with a two-fold increase in mortality among girls. This discovery led to the withdrawal of the vaccine.[1] Had it not been withdrawn, it could have cost at least ½ million additional female deaths per year in Africa alone.[2][3]

The organization[edit]

The Bandim Health Project is led by Peter Aaby. The National Research Coordinator is Amabelia Rodrigues. Since the project's foundation in 1978, more than 700 scientific articles have been published, and more than 40 PhD or doctoral degrees and 13 Masters of International Health degrees have been obtained by researchers employed by the project.


Bandim Health Project is placed in Guinea-Bissau and also has a small department at Statens Serum Institut in Denmark. Bandim Health Project is also affiliated with University of Southern Denmark, where Peter Aaby is an adjunct professor and Christine Benn holds a professorship in Global Health.

See also[edit]


  1. ^ WHO. "Expanded programme on immunization (EPI). Safety of high titre measles vaccines". Wkly Epidemiol Rec. 67: 1992. PMID 1449986.
  2. ^ Aaby, P., et al. "Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies." Lancet 361.9376 (2003): 2183–88.
  3. ^ Aaby, P. "Being wrong in the right direction?" Lancet 364.9438 (2004): 984.

External links[edit]